← Back to Search

REDUCE-BP Intervention for High Blood Pressure (REDUCE-BP Trial)

N/A
Waitlist Available
Led By Niteesh K Choudhry, MD, PhD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Hypertension diagnosis on EPIC Problem list OR at least 2 visits with an encounter diagnosis of hypertension on different dates, with any during the last 24 months performing provider
Current age 18-85 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

REDUCE-BP Trial Summary

This trial will test whether a multicomponent intervention targeting providers and leveraging health information technology can reduce health disparities in racial and ethnic minorities.

Who is the study for?
This trial is for adults aged 18-85 with uncontrolled high blood pressure, who have seen their primary care physician at least once in the past two years and have a hypertension diagnosis recorded. It's focused on patients using the EPIC EHR system.Check my eligibility
What is being tested?
The REDUCE-BP Intervention aims to help doctors manage high blood pressure better using enhanced tools within the electronic health record (EHR) system. This includes new dashboards, decision support, and improved patient communication methods.See study design
What are the potential side effects?
Since this intervention involves non-medical changes to how doctors use EHR systems, there are no direct medical side effects associated with it. However, any change in treatment resulting from improved management may carry its own risks.

REDUCE-BP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with high blood pressure.
Select...
I am between 18 and 85 years old.

REDUCE-BP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in systolic blood pressure
Secondary outcome measures
Change in diastolic blood pressure
Percentage of patients with guideline-concordant medications
Percentage of patients with intensification of medication
+2 more
Other outcome measures
Clinical encounters

REDUCE-BP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
Providers within the clinics randomized to the intervention arm will receive a variety of EHR-based tools for eligible patients with uncontrolled hypertension.
Group II: Control ArmActive Control1 Intervention
Providers within the clinics randomized to usual care will receive no EHR tools, except those currently available in clinical practice.

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,599 Previous Clinical Trials
11,445,398 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
373 Previous Clinical Trials
1,197,353 Total Patients Enrolled
Niteesh K Choudhry, MD, PhDPrincipal InvestigatorBrigham and Women's Hospital
10 Previous Clinical Trials
304,751 Total Patients Enrolled

Media Library

REDUCE-BP Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05030467 — N/A
High Blood Pressure Research Study Groups: Intervention Arm, Control Arm
High Blood Pressure Clinical Trial 2023: REDUCE-BP Intervention Highlights & Side Effects. Trial Name: NCT05030467 — N/A
REDUCE-BP Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05030467 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who qualifies for enrollment in this research project?

"This medical trial involves 2000 participants that are between the ages of 18 and 85, with a preexisting diagnosis of hypertension."

Answered by AI

Does this research endeavor extend to octogenarians?

"This medical trial seeks participants that are in the 18-85 year old age range."

Answered by AI

Are there any open spaces available in this clinical research project?

"Upon inspection of clinicaltrials.gov, this research has concluded its recruitment process. It was initially announced on May 3rd 2022 and last amended on the 5th of that same month. Fortunately, 821 further studies are currently open to enrolment candidates."

Answered by AI

Who else is applying?

How old are they?
65+
What site did they apply to?
Advocate Health Care
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

Paresis unknown besides the fact that I'll bees and have it obese for a while.
PatientReceived 1 prior treatment
Blood pressure recently shot up to 170 over 109 and I don't know why besides the fact that I'll bees and have it obese for a while.
PatientReceived no prior treatments
~744 spots leftby May 2024